InvestorsHub Logo
Followers 0
Posts 69
Boards Moderated 0
Alias Born 02/14/2021

Re: ATLnsider post# 356366

Friday, 02/19/2021 3:13:43 PM

Friday, February 19, 2021 3:13:43 PM

Post# of 709372
Doesn't Merck have something to do with this Cognate deal? I mean they have to, right? Since Merck is ultimately behind everything happening with NWBO, they have to be behind this too, right? Just connect a few more dots for us and I'll be all in!

In all seriousness, there have been a lot of people who have left the employ of NWBO over the years. Pretty much all of them have gone on to bigger and better - and certainly more productive - careers. That most of them would remain in the bio tech field and that NWBO would eventually cross paths with them again at some point is not in the least surprising.

The sale of Cognate is a giant distraction. I don't believe it has anything to do with NWBO. Cognate is a company that has grown exponentially in the last few years precisely because it disconnected from NWBO (a deal that enriched the NWBO CEO but not NWBO's shareholders). Cognate is booming because of its contracts with companies that are not NWBO - i.e., companies that actually produce things. We don't know if Charles River will even keep the NWBO contract, but they would be fools to dump a contract that pays them a fee for doing nothing. To believe NWBO has anything to do with this deal seems quite a stretch - especially when some of us remember NWBO's last association with Cognate being the settlement of a dispute that almost led to a lawsuit. But, hey, keep dreaming and maybe one day your dream will come true.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News